1.Foldvari, M., Jaafari, M.R., Mezei, C., and Mezei, M. 1998. Targeting of liposomes through immunoglobulin superfamily domains: P0 protein as a model. Drug Delivery 5: 183-195 (Impact factor 1.413).
2.Jaafari, M.R. and Foldvari, M. 1999. P0 protein mediated targeting of liposomes to melanoma cells with high level of ICAM-1 expression. J. Drug Targeting 7:101-112 (Impact factor 2.885).
3.Jaafari, M.R. and Flodvari, M. 2002 Targeting of liposomes to human keratinocytes through adhesive peptides from immunoglobulin domains in the presence of IFN-g. Drug Delivery, 9:1-9 (Impact factor 1.413).
4.Jaafari, M.R. and Foldvari, M 2002. Targeting of liposomes to melanoma cells with high level of ICAM-1 expression through adhesive peptides from immunoglobulin domains. J. Pharm. Sci. 91:396-404 (Impact factor 2.906).
5.Tafaghodi M., Sajadi Tabassi A., Jaafari M.R. (2004) Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigrapgy. Int. J. Pharmaceutics, 280: 125-135 (Impact factor 2.962).
6. Foldvari M., Jaafari M.R., Radhi J., Segal D., (2005) Efficacy of the anti-adhesin, 2-O-propyl-octyl -Gal NAc (1-4) -Gal (Fimbrigal-P), in a rat oral candidiasis model. Antimicrob. Agents Chemother. 49: 2887-2894 (Impact factor 4.802).
7. Balali-Mood M, Hefazi M, Mahmoudi M, Jalali E, Attaran D, Maleki M, Razavi ME, Zare G, Tabatabaee A, Jaafari MR. (2005) Long-term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans. Fundam. Clin. Pharmacol.19 (6): 713-21(Impact factor 2.372).
8. Tafaghodi M., Sajadi Tabassi S.A., Jaafari M.R., (2006), Formulation, characterization and release studies of alginate microsphere encapsulated with tetanus toxoid. J. Biomater. Sci. Polymer Edn, 17: 909-924. (Impact factor 2.505).
9. Malaekeh-Nikouei B., Sajadi Tabassi S. A., Jaafari M. R. (2006) The Effect of Different Grades of PLGA on Characteristics of Microspheres Encapsulated with Cyclosporine A., Curr Drug Deliv. 2006 Oct; 3(4):343-9 (ISI, no impact factor).
10. Jaafari M.R., Attieh Ghafarian A.,Farrokh-Gisour A., Samiei A., Tavassoti Kheiri M., Mahboudi F., Barkhordari F., Khamesipour A., McMaster W.R. (2006) Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice, Vaccine, 24: 5708-5717(Impact factor 3.616).
11. Tafaghodi M., Sajadi Tabassi S.A., Jaafari M.R., (2006), Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanous toxoid and CpG-ODN. Int. J. Pharmaceutics, 319: 37-43 (Impact factor 2.962).
12. Malaekeh-Nikouei B., Sajadi Tabassi S. A., Jaafari, M. R., Davies N. M., The effect of complexation on characteristics and drug release of PLGA microspheres loaded by cyclosporine-cyclodextrin complex, Journal of Drug Delivery Science andTechnology,September/November 2006, 16 (5): 345-350 (Impact factor 0.588).
13. Tafaghodi M., Jaafari M.R., Sajadi Tabassi S.A., (2006), Nasal immunization studies using liposomes loaded with tetanous toxoid and CpG-ODN. Eur. J. Pharm. Biopharm. 64: 138-145 (Impact factor 3.151).
14. Tabbakhian M., Tavakoli N., Jaafari M.R., Daneshamouz S., (2006) Enhancement of Follicular Delivery of Finasteride by Liposomes and Niosomes: 1. In Vitro Permeation and In Vivo Deposition Studies Using Hamster Flank and Ear Models, Int. J. Pharm., 323: 1-10 (Impact factor 2.962).
15. Badiee A, Jaafari MR, Khamesipour A.(2007) Leishmania major: Immune response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomes. Exp. Parasitol. 115(2): 127-134 (Impact factor 1.773).
16. Iranshahi M, Arfa P, Ramezani M, Jaafari MR, Sadeghian H, Bassarello C, Piacente S, Pizza C.(2007) Sesquiterpene coumarins from Ferula szowitsiana and in vitro antileishmanial activity of 7-prenyloxycoumarins against promastigotes.Phytochemistry. 2007 Feb; 68 (4): 554-61 (Impact factor 3.104).
17. Jaafari M.R., Badiee A., Khamesipour A., Samiei A., Soroush D., Tavassoti Kheiri M., Barkhordari F., McMaster W.R., Mahboudi F. (2007) The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome, Vaccine 25: 6107-6117 (Impact factor 3.616).
18 Monajjemi M., Afsharnezhad S., Jaafari M.R., Abdolahi T., Nikosade A., Monajemi H., (2007), NMR shielding and a thermodynamic study of the effect of environmental exposure to petrochemical solvent on DPPC, an important component of lung surfactant, Russian Journal of Physical Chemistry A, 81(12): 1956-1963 (Impact factor 0.438).
19. Badiee A, Jaafari MR, Samiei A, Soroush D, Khamesipour A.Coencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB/c mice. Clin Vaccine Immunol. 2008 Apr;15(4):668-74 (Impact factor 2.373).
20. Tafaghodi M., Jaafari M.R., Sajadi Tabassi S.A., (2008) Nasal immunization studies by cationic, fusogenic and cationic-fusogenic liposomes encapsulated with tetanous toxoid, Curr Drug Deliv. 5(2); 108-113 (ISI, no impact factor).
21. Malaekeh-Nikouei B, Sajadi Tabassi SA, Jaafari MR.(2008 May) Preparation, characterization, and mucoadhesive properties of chitosan-coated microspheres encapsulated with cyclosporine a. Drug Dev Ind Pharm. 34 (5): 492-8 (Impact factor 0.96).
22. Sajadi Tabassi S.A., Tafaghodi M., Jaafari M.R., (2008) Induction of high antitoxin titers against tetanous toxoid in rabbits by intranasal immunization with dextran microspheres, Int. J. Pharm. 2008 Aug 6; 360 (1-2):12-7 (Impact factor 2.962).
23. Golmohammadzadeh S.,Jaafari M.R., Khalili N., (2008) Evaluation of liposomal and conventional formulations on the human percutaneous absorption of octyl methoxycinnamate using stripping method. Journal of Cosmetic Science 59 (5): 385-398 (Impact factor 0.392).
24. Malaekeh-Nikouei B., Jaafari M. R., Sajadi Tabassi S. A., Samiei A., (2008) The Enhancement of Immunosuppressive Effects of Cyclosporine A on Human T-Cells Using Fusogenic Liposomes, Colloids and Surface B: biointerfaces, 67: 238-244 (Impact factor 2.6).
25. Hosseinzadeh H,Jaafari MR, Shamsara J. Selective inhibitory effect of adenosine A1 receptor agonists on the Selective inhibitory effect of adenosine A1 receptor agonists on the proliferation of human tumor cell lines. Iran Biomed J. 2008 Oct;12(4): 203-208 (ISI, no impact factor).
26. Varasteh A.R., Hashemi M., Baranzadeh N.,Jaafari M.R., (2008) Optimization of Anti-Rh D Immunoglobulin Stability in the Lyopphilization Processes. Iranian J. Basic Med. Sc. 11 (1): 55-61(ISI, no impact factor).
27. Badiee A., Jaafari M.R., Khamesipour A., Samiei A., Soroush D., Tavassoti Kheiri M., Barkhordari F., McMaster W.R., Mahboudi F. (April 2009) The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63), Exp. Parasitol. 121 (4): 362-9 (Impact factor 1.773).
28. Razzazan A, Saberi MR, Jaafari MR. (2008) Insights from the analysis of a predicted model of gp63 in Leishmania donovani.Bioinformation. 3 (3): 114-8 (Impact factor 1.43).
29.Jaafari M.R., Bavarsad N, Fazly Bazzaz B.S., Samiei A., Dina Soroush, Ghorbani S., Lotfi Heravi M.M., Khamesipour A. (June 2009) The Effect of Topical Liposomes Containing Paromomycin Sulfate (PM) in the Course of Leishmania major Infection in Susceptible BALB/c Mice. Antimicrob. Agents Chemother. 53 (6): 2259-2265 (Impact factor 4.802).
30. Abrishami M, Ganavati SZ, Soroush D, Rouhbakhsh M, Jaafari MR, Malaekeh-Nikouei B. Preparation, characterization, and in vivo evaluation of nanoliposomes-encapsulated bevacizumab (avastin) for intravitreal administration.Retina. 2009 May;29(5):699-703 (Impact factor 2.932).
31. Huang Z, Jaafari MR, Szoka FC Jr. (2009) Disterolphospholipids: Nonexchangeable Lipids and Their Application to Liposomal Drug Delivery.Angew Chem Int Ed 48: 4146-4149(Impact factor 11.829).
32. Badiee A, Jaafari MR, Khamesipour A, Samiei A, Soroush D, Kheiri MT, Barkhordari F, McMaster WR, Mahboudi F. (2009) Enhancement of immune response and protection in BALB/c mice immunized with liposomal recombinant major surface glycoprotein of Leishmania (rgp63): The role of bilayer composition.Colloids Surf B Biointerfaces. 74: 37-44 (Impact factor 2.6).
33. Hadizadeh F, Moallem SA, Jaafari MR, Shahab M, Alahyari M, Rameshrad M, Samiei A. (2009) Synthesis and immunomodulation of human lymphocyte proliferation and cytokine (interferon-gamma) production of four novel malonitrilamides.Chem Biol Drug Des. 73(6):668-73 (Impact factor 2.473).
34. Amin M,Jaafari MR, Tafaghodi M. (2009) Impact of chitosan coating of anionic liposomes on clearance rate, mucosal and systemic immune responses following nasal administration in rabbits.Colloids Surf B Biointerfaces. 74: 225-229 (Impact factor 2.6).
35. Ebrahimnejad P, Dinarvand R, Sajadi SA, Atyabi F. Ramezani F, Jaafari MR, 2009, Preparation and Characterization of Poly Lactide-co- glycolide Nanoparticles of SN-38. PDA J. Pharm. Sci. Technol. 63: 512-520 (ISI, no impact factor).
36. Ebrahimnejad P, Dinarvand R, Sajadi SA, Jaafari MR, Movaghari F, Atyabi F, 2009, Development and Validation of an Ion-pair HPLC Chromatography for Simultaneous Determination of Lactone and Carboxylate Forms of SN-38 in Nanoparticles. Journal of Food and Drug Analysis, 17 (4): 246-256 (Impact factor 0.63).
37. Hadizadeh F, Jaafari MR, Samiei A, Mostafavirad A and Mohammadian E, (2009) Synthesis and In Vitro Leishmanicidal Effects of Conformationally Restricted Analogues of Pentamidine, Iranian J. Pharm. Res., 8 (4): 257-262 (Impact factor 0.235).
38. Raji AR, Jaafari MR, 2009, Transmission electron microscopy study of the alveolar septum in adult camel, Indian Veterinary Journal, 86 (7): 719-721. (Impact factor 0.056).
39. Hejazi H, Tasbihi M, Jaafari MR, Badiee A, Pestechian N, A Javadi A, Khamesipour A, 2010, The Role of Liposomal CpG ODN on the Course of L. major Infection in BALB/C Mice, Iranian J. Parasitol. 5 (1): 47-54 (ISI, no impact factor).
40. Golmohammadzadeh S, Jaafari MR, Hosseinzadeh H, (2010), Does Saffron Have Antisolar and Moisturizing Effects?, Iranian J. Pharm. Res., 9 (2): 1331-40 (Impact factor 0.235).
41. Ebrahimnejad P, Dinarvand R, Sajadi A, Jaafari MR, Nomani AR, Azizi E, Rad-Malekshahi M, Atyabi F. (2010 June), Preparation and in vitro evaluation of actively targetable nanoparticles for SN-38 delivery against HT29 cell lines.Nanomedicine: NBM. 6 (3): 478-85 (Impact factor 5.44).
42. Tafaghodi M., Khamesipour A.,Jaafari M.R. (Dec. 2010), Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental Autoclaved Leishmania major (ALM) and Quillaja saponins, Tropical Biomedicine 27(3): 639–650 (Impact factor 0.649).
43. Tafaghodi M., Khamesipour A., Jaafari M.R., (2011 May), Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN, Parasitol Res. 108(5):1265-1273 (Impact factor 1.721).
44. F. Vahedi, M.R. Jaafari, M.,R. Mahmoudi, M. (Dec. 2010) The Effect of Using Cationic Liposomes Encapsulating pcDNA3.1+PA Plasmids on Humoral Immune Response in Mice, Iranian Journal of Immunology 7 (4): 210-216 (ISI, no impact factor).
45. Iman M, Huang Z, Szoka FC, Jaafari MR, (2011 April 15), Characterization of the Colloidal Properties, In vitro Antifungal Activity, Antileishmanial Activity and Toxicity in Mice of a Distigmasterylhemisuccinoyl-glycero-phosphocholine Liposome-Intercalated Amphotericin B. Int J Pharm.408 (1-2): 163-72 (Impact factor 2.962).
46. Ebrahimnejad P, Dinarvand R, Jaafari MR, Sajadi SA, Atyabi F, (2011 Mar 15)Characterization, blood profile and biodistribution properties of surface modified PLGA nanoparticles of SN-38.Int J Pharm.406 (1-2): 122-7 (Impact factor 2.962).
دانشکده داروسازی
